Medulloblastoma (MB) is the most common pediatric brain tumor, comprising four distinct molecular variants, one of which characterized by activation of the Sonic Hedgehog (SHH) pathway, driving 25–30% of sporadic MB. SHH-dependent MBs arise from granule cell precursors (GCPs), are fatal in 40–70% of cases and radioresistance strongly contributes to poor prognosis and tumor recurrence. Patched1 heterozygous (Ptch1 +/−) mice, carrying a germ-line heterozygous inactivating mutation in the Ptch1 gene, the Shh receptor and negative regulator of the pathway, are uniquely susceptible to MB development after radiation damage in neonatal cerebellum. Here, we irradiated ex-vivo GCPs isolated from cerebella of neonatal WT and Ptch1 +/− mice. Our results highlight a less differentiated status of Ptch1-mutated cells after irradiation, influencing DNA damage response. Increased expression levels of pluripotency genes Nanog, Oct4 and Sal4, together with greater clonogenic potential, clearly suggest that radiation induces expansion of the stem-like cell compartment through cell-reprogramming and self-renewal maintenance, and that this mechanism is strongly dependent on Nanog. These results contribute to clarify the molecular mechanisms that control radiation-induced Shh-mediated tumorigenesis and may suggest Nanog as a potential target to inhibit for adjuvant radiotherapy in treatment of SHH-dependent MB.
Medulloblastoma (MB) is the most common childhood malignancy of the central nervous system (CNS) and, despite aggressive multimodal therapy with surgery, radiation, and chemotherapy, its 5-year survival rates have only approached >60%1. MBs arise from granule cell precursors (GCPs), a transient population of progenitors that, in normal conditions, give rise to granule neurons of the cerebellum2.
In 2003, for the first time, a CD133+ cell subpopulation with stem cell properties was isolated in vitro from human brain tumors. The CD133+ cancer stem cell (CSC) fraction, ranging from 19 to 29% in highly aggressive glioblastomas and from 6 to 21% in MBs, correlated closely with an in vitro primary sphere formation assay3. There are many genetic pathways and elements involved in the control of self-renewal and differentiation of normal SCs as well as CSCs, e.g. PI3K/Akt, JAK/STAT, Wnt/β-catenin, Sonic Hedgehog (SHH), Notch, NF-κB and ABC superfamily among others4. In particular, SHH signaling sustains embryonic and postnatal development of neural SCs of the forebrain subventricular zone and hippocampus5,6,7,8,9. Moreover, human gliomas display a stemness signature, and SHH-GLI signaling regulates the expression of stemness genes (e.g. Nanog, Oct4, Sox2, CD133) and the self-renewal of CD133(+) glioma cancer stem cells10,11. Another SHH target organ is the cerebellum, where SHH is critically required to keep transit-amplifying GCPs in an undifferentiated state and promote their proliferation12,13,14. However, constitutive activation of this pathway can cause MB15.
Mice with one copy of the Ptch1 gene knocked out (Ptch1 +/−), characterized by aberrant activation of the Shh signaling pathway, are developmentally nearly normal but show a marked predisposition to development of tumors, including MB. Remarkably, they are very radiosensitive16,17. Our previous work has shown that irradiation of Ptch1 +/− mice during postnatal days 1–10, when GCPs are highly proliferative, significantly increases MB frequency18,19.
Self-renewal and pluripotency are two fundamental characteristics of SCs, and are controlled by diverse regulatory factors, including microRNAs (miRNAs). miR-125 isoforms promote neural conversion of human embryonic stem cells. Boissart et al.20 have shown that antagonizing miR-125 isoforms, independently or in combination, compromised to the same extent the efficiency of neural induction and that both are able to target Lin28, an RNA-binding protein promoting the proliferative capacity of neural progenitor cells in brain development21. More recently, miR-125b has been shown to target Lin28 during mouse embryoid body formation22. In addition, when both miR-125 isoforms were antagonized simultaneously, expression of all pluripotency markers (including OCT4 and NANOG) was significantly induced20.
In our laboratory, we recently identified a subset of miRNAs (i.e. let-7 family and mir-17∼92 cluster), controlling different biological functions, whose expression was altered in GCPs by radiation alone or in combination with Shh-deregulation23. An increased level of miR-17 and an associated decreased expression of Let-7 family members after irradiation, suggested an interaction of radiation with Shh-deregulation in sustaining a phenotype shift toward stemness. Importantly, their deregulation persisted in radio-induced MB23.
In the current work, through extensive characterization of GCPs response to radiation, we show for the first time that irradiated Ptch1 +/− GCPs re-acquire the capacity for long-term self-renewal, reprogramming to a less differentiated cell type through Nanog activation and, importantly, that this process may drive radiogenic Shh-mediated MB tumorigenesis.
DNA damage response (DDR) in WT and Ptch1 +/− GCPs
GCPs isolated from cerebella of WT and Ptch1 +/− mice at P2 and irradiated ex-vivo with 1-Gy of X-rays or sham-irradiated, were analyzed by flow cytometry at 4, 24 and 40 hours after irradiation to check for accumulation of γ-H2AX, a typical biomarker for DNA double-strand breaks (DSBs). As shown in Fig. 1a, sham-irradiated Ptch1 +/− GCPs showed a higher level of γ-H2AX-positive cells compared with WT GCPs, confirming that Shh signaling pathway deregulation per se promotes genetic instability24. Consistent with the well-recognized role of ionizing radiation as inductor of DNA DSBs25, the accumulation of γ-H2AX strongly increased after irradiation, irrespective of GCPs Ptch1 genotype. To understand how DNA DBSs induction was paralleled by apoptosis in the two cell populations, we quantified apoptosis of cells by caspase-3/7 assay. Despite generally higher levels of DNA DSBs, we found that Ptch1 +/− GCPs were less prone to radiation-induced apoptosis at all time points analyzed (Fig. 1b). Forty hours after irradiation, Ptch1 +/− GCPs showed a percentage of apoptotic cells comparable to unirradiated Ptch1 +/− cells. Notably, at this experimental time, Ptch1 +/− GCPs maintain a high level of γ-H2AX-positive cells triggering persistence of genomic instability. In contrast, WT GCPs at 40 h have a persistent higher percentage of apoptotic cells compared with unirradiated counterparts (P < 0.0001), notwithstanding similar DSBs levels.
The DDR can differ depending on the differentiation status of cells, and this difference is ascribable to p21 activation and, at least in part, to its ability to inhibit p53 then impending apoptosis26. To verify this mechanism in our experimental system, we checked the expression of p21 and p53 in sham-irradiated and irradiated WT and Ptch1 +/− GCPs. The expression level of p21 mRNA (Fig. 2a) and protein (Fig. 2c) significantly increased after irradiation in both cell lineages, but this was not associated to transcriptional activation of p53 in Ptch1 +/− GCPs (Fig. 2b). Conversely, in irradiated WT GCPs we found a statistically significant increase of p53 mRNA with respect to sham-irradiated WT cells (Fig. 2b; P < 0.05). Noteworthy, the higher expression level of the survival factor Bcl2 and the concomitant lower expression of Bax, a pro-apoptotic Bcl-2-family protein, in irradiated Ptch1 +/− GCPs compared with WT cells (Fig. 2c), is in line with the lower degree of apoptosis found in Ptch1-mutant cells. This result is supported by data obtained through propidium iodide staining followed by flow cytometric analysis (Supplementary Information file (Table S1)), showing a lower percentage of cell death (hypodiploid peak) and a higher proliferation rate of Ptch1 +/− GCPs compared with normal cells, in all experimental conditions.
Altogether, these results underline a different DDR of Ptch1 +/− compared with WT GCPs, suggesting a less differentiated status of Ptch1-mutant cells and, importantly, that radiation exposure potentiates this difference.
Cell-reprogramming and cell renewal of Ptch1 +/− GCPs is induced by irradiation
To explore potential differences in cell differentiation state due to Ptch1 allelic status, we first examined the expression of transcription factors that are known to induce stem-like properties in differentiated cells, i.e., Nanog, Oct4, Sal4 and Sox227. Unirradiated Ptch1 +/− GCPs showed a general statistically significant increase in the expression of all genes analyzed compared to WT GCPs, confirming that increased Shh signalling per se causes expansion of the stem cell pool (Fig. 3a–d)28. Although irradiation significantly increased expression levels of Nanog, Oct4 and Sal4 in WT GCPs (Fig. 3a–c), their expression was dramatically higher in irradiated Ptch1 +/− compared with WT GCPs at 4 hours post-irradiation (Fig. 3a–c), implying that Shh deregulation and irradiation synergize in driving expansion of a highly undifferentiated cell population. Interestingly, no modulation of Sox2 expression level was detected after irradiation, irrespective of genotype (Fig. 3d).
In order to extend our investigation of cell reprogramming as part of the DDR response in Ptch1 +/− GCPs, we also tested the expression level of the RNA binding protein Lin28 and miR-125b, as it is known that their equilibrium maintains stem cell self-renewal and plasticity or drives neuronal lineage commitment and differentiation29. We therefore investigated the expression levels of Lin28 and miR-125b in Ptch1 +/− and WT GCPs. As shown in Fig. 3e, Lin28 expression was statistically significantly higher in sham-irradiated Ptch1 +/− compared with WT GCPs (P < 0.05), and this difference was strikingly increased after exposure to ionizing radiation, especially in combination with Ptch1 heterozygosity (2.5-fold increase). Accordingly, there was a lower miR-125b expression level (Fig. 3f) in sham-irradiated Ptch1 +/− GCPs compared with WT counterparts (P < 0.001) and this difference was exacerbated after irradiation (2.3-fold decrease), again indicating a less differentiated phenotype of irradiated Ptch1 +/− GCPs.
To better characterize dedifferentiated cells, we tested their ability to grow as neurospheres. As shown in Fig. 4b, activation of the Shh pathway was sufficient to increase the number of neurosphere-forming cells compared with WT cells (1.5-fold). Noteworthy, clonogenicity of Ptch1 +/− GCPs significantly increased after irradiation (P < 0.05). Moreover, after morphometric analysis of neurospheres, we show that sham-irradiated Ptch1 +/− GCPs form colonies with larger average area compared to that observed in WT cells (Fig. 4c). Again, this trend was accentuated after irradiation, and we obtained neurospheres with an area >10 μm2 only from irradiated Ptch1 +/− GCPs.
Altogether, these results support the hypothesis that radiation induces expansion of the stem-like cell compartment through cell reprogramming and self-renewal maintenance, and that this mechanism is strongly enhanced by activation of the Shh signaling pathway.
Nanog controls proliferation, apoptosis and stemness in irradiated Ptch1 +/− GCPs
Besides the well-recognized role of Nanog as transcription factor in embryonic SCs and in maintaining pluripotency27,30,31, Nanog is also a critical mediator of Shh-driven self-renewal of neural SCs. Both Nanog and Gli1 are highly expressed in postnatal cerebellar NSCs and in Shh-dependent mouse and human MB SCs32. Therefore, we followed Nanog mRNA expression in GCPs until 72 h, and found it upregulated at 24, 48 and 72 h post-irradiation (Fig. 5a). Similarly, Gli1 expression was upregulated at 48 and 72 h (Fig. 5b). We thus focused on Nanog in our efforts to characterize the dedifferentiation process.
We silenced Nanog expression in our cell lineages (siNanog GCPs). In sham-irradiated condition, we observed statistically significant reduction of cell viability in cultures of both siNanog-WT and -Ptch1 +/− GCPs compared with untreated cells (siCTR GCPs). Irrespective of genotype, cell viability strongly decreased after irradiation, although this was much more evident in Ptch1 mutants (Fig. 5c). Decreased cell viability is attributable to concomitant increased level of apoptosis, as shown in Fig. 5d.
Importantly, the number of neurosphere-forming cells decreased in siNanog Ptch1 +/− GCPs compared with siCTR Ptch1 +/− in both experimental groups, reaching statistical significance in irradiated condition (Fig. 5f; P < 0.05). This effect is also reflected in the lower mean size of neurospheres, as shown in Fig. 5e,g.
Consequences of radiation-induced expansion of the stem-like cell compartment on cerebellar development and MB onset
To assess whether the different DDR observed ex vivo between WT and Ptch1 +/− GCPs leads to cerebellar development anomalies in vivo, we measured cerebellar area at different ages (P5, P8 and P14) of postnatal development, occurring during the first 21 postnatal days in the mouse33. In absence of irradiation, histological examination of cerebellar midsagittal sections from WT and Ptch1 +/− mice showed comparable foliation patterns (data not shown); however, as shown in Fig. 6a,b, Ptch1 +/− mouse cerebella were larger than WT cerebella at P8 (5.6 vs 4.5 × 106; P < 0.05) and P14 (8.2 vs 7.6 × 106; P < 0.05). These data, in agreement with the higher proliferation index of Ptch1 +/− GCPs (see Supplementary Information file (Table S1)), underline that Shh activation, while not altering the basic foliation pattern, increases the overall size of the cerebellum, as already reported by other authors34.
After irradiation, WT mice showed a statistically significant decrease of cerebellum area compared with age-matched sham-irradiated mice at all time-points (Fig. 6a). Of note, no statistically significant dimensional difference was found in Ptch1 +/− mouse cerebella after IR-exposure (Fig. 6b). These results strongly suggest that the expansion of the stem-like compartment and the concomitant inhibition of radiation-induced apoptosis observed in Ptch1 +/− GCPs after irradiation counteracts the cerebellar reduction by radiation, as also observed in rats35.
On the other hand, the Nanog-driven expansion of a stem-like cell compartment which displays genomic instability due to the accumulation of DNA damage (see Fig. 1A), could be strictly related to the dramatically high MB incidence typical of the Ptch1 +/− mouse model in response to radiation18,19.
As Nanog mediates GCPs response to radiation, we asked whether its expression could be dose dependent. Therefore, we also measured Nanog expression in WT and Ptch1 +/− GCPs irradiated with 3 Gy. As shown in Fig. 6c, a statistically significant dose-dependent increase of Nanog mRNA was found in WT cells. In Ptch1 +/− GCPs this dose dependence was more marked compared with WT GCPs. We then checked Nanog expression in spontaneous (n = 9) and radio-induced (n = 11) MBs, as well as in adult cerebellum (n = 4) for comparison. As shown in Fig. 6d, the mean value of Nanog expression in radio-induced MBs was statistically significantly higher compared with that found in spontaneous tumors (P < 0.05). As expected, no Nanog expression was detected in adult cerebellum.
Tumorigenesis is thought to depend on capacity for long-term self-renewal. During mouse normal cerebellum development, GCPs do not exhibit this capacity: they proliferate for 2–3 weeks after birth, then exit the cell cycle and undergo terminal differentiation. Deletion of one copy of Ptch1 increases proliferation of GCPs12,13,14 but many of these are still able to differentiate and only a subset of them continues to proliferate and form tumors with a spontaneous MB rate of 8% on CD1 genetic background18. One explanation for this is that full transformation of GCPs requires changes that only occur in a subset of GCPs.
The aim of our study was the clarification of mechanisms that underlie Shh-dependent radio-induced MB tumorigenesis, and for this we took advantage of the use of highly radiosensitive Ptch1 +/− mice16,17. In particular, the present study addresses the question of the effects of DDR on GCPs self-renewal, with particular emphasis on the role of Nanog in GCPs dedifferentiation and DDR processing by highly purified GCPs irradiated ex vivo.
To explore how deregulated Shh signaling and tissue injury caused by radiation contribute to MB tumorigenesis, we first investigated the accumulation of γ-H2AX, a biomarker of DNA double strand breaks, in WT and Ptch1 +/− GCPs at different time points after irradiation and in respective control cells. We detected higher levels of γ-H2AX-positive cells in Ptch1 +/− compared with WT GCPs, confirming that Shh signaling deregulation is able to drive towards an unstable cell phenotype favoring accumulation of genomic alterations24. Despite higher levels of DNA damage, we found that Ptch1 +/− GCPs were less prone to spontaneous and radio-induced apoptosis, showed higher expression of the survival factor Bcl2, and higher proliferation rates than WT GCPs. This might be due to impairment in radiation–induced checkpoint activation24. The cellular response to DNA damage usually depends on the tumor suppressor p5336. In agreement with our previous in vivo data19, we report here that ex vivo irradiation of Ptch1 +/− GCPs does not activate p53. The lack of p53 activation after ionizing radiation, combined with weak activation of p21, may suggest dedifferentiation of GCPs to a stem-like cell phenotype leading to cell-cycle entry and self-renewing divisions, as it usually happens in SCs26.
In agreement, increased levels of Lin28 associated with decreased expression of miR-125b after radiation treatment, strongly suggest a less differentiated status of Ptch1 +/− compared with WT GCPs. Notably, the expression of factors that are known to induce stem-like properties in differentiated cells, i.e., OCT4, Nanog and Sal428,37,38, were also significantly more expressed in Ptch1 +/− GCPs with respect to control cells. Also, their expression was higher compared with irradiated WT GCPs, showing that Shh deregulation and irradiation synergize to amplify the stem cell compartment. In support of these molecular results, clonogenicity of Ptch1 +/− GCPs significantly increased after irradiation.
Our data suggest that endogenous activation of both Oct4 and Nanog expression could have a role in the reprogramming process induced by irradiation. Of note, Nanog is a critical mediator of Shh-driven self-renewal of NSCs and its transcriptional activation is directly sustained by Gli1 and Gli232; moreover, Zbinden and colleagues39 demonstrated that Nanog is situated in a neat balance between p53 and Shh signaling, whose deregulation results in an aberrant expression of Nanog. Focusing on Nanog we show, for the first time, that Nanog depletion abrogates the enhancing response to radiation controlling cell viability, apoptosis, cell reprogramming and cell-renewal of Ptch1 +/− GCPs.
Although in Ptch1 mutant cells all biological endpoints analyzed are magnified by an aberrant Shh pathway activation, irradiation similarly affects WT GCPs, highlighting a general cell response to the radiogenic insult. However, at this stage of postnatal development GCPs are, independently by genotype, strongly influenced by Shh pathway; moreover, in our ex-vivo experimental set-up, GCPs viability is maintained only adding Shh to the medium. Consequently, our results highlight a synergic interaction between Shh pathway and radiation in driving cell reprogramming and self-renewal maintenance, through Nanog activation.
Self-renewal in neural progenitor cells has been previously described in response to appropriate signals and factors such as proto-oncogenes Myc and Bm140,41 and the Wnt signaling42. These results, focused on the knowledge of molecular mechanisms controlling the induction of neural progenitor cells, provide a near limitless source of neural cells for cell-replacement therapies in vivo and cell-based in vitro models of neurological disease. On the contrary, little information is available on somatic normal cell dedifferentiation after exposure to physical stress.
Many studies have underlined that radiation-induced injury in stem cells may closely associate with future cancer risks43,44,45. Thus, the Nanog-driven expansion of a highly unstable stem-like compartment, due to the accumulation of DNA damage, could be strictly related to the dramatically high MB incidence characteristic of the Ptch1 +/− mouse model in response to radiation18. In support of this, we report a higher Nanog expression in radio-induced MBs compared with spontaneous ones. Moreover, a key role of the miR-17–92 cluster family in the control of MB progression has been shown46. Significant differences in miR-19a expression emerged between radio-induced and spontaneous MB in our previous work23. These data strengthen our conclusions on the role of Nanog in driving radiation-induced tumorigenesis, being the cluster miR-17-92 a direct transcriptional target of Nanog47. Importantly, the dose-dependent increase of Nanog expression in GCPs closely reflects the well-described dependence on dose of MB incidence in Ptch1 +/− mice48.
In conclusion, our study provides original insights, summarized in Fig. 7, in the interaction between radiation exposure and Shh-deregulation in sustaining a phenotype shift toward stemness in the Shh-MB cell-of-origin. Importantly, we show, for the first time, that Nanog depletion abrogates the response to radiation, controlling cell viability and apoptosis as well as clonogenicity of Ptch1 +/− GCPs. These results help clarify the complex molecular mechanisms that control radiation-induced Shh-mediated tumorigenesis. Moreover, as aberrant activation of SHH pathway is responsible for ~25–30% of sporadic human MB49, for which radiotherapy is an essential component of multimodal treatment, our results might also aid development of new therapeutic strategies to overcome SHH-MB radioresistance, with Nanog as a potential target.
GCPs isolation and irradiation
GCPs were purified from WT and Ptch1 +/− mouse cerebella at P2 and maintained in culture as described23. Cells were irradiated with 1 Gy of X-rays or sham-irradiated using a Gilardoni CHF 320 G X-ray generator (Gilardoni S.p.A., Mandello del Lario, Italy) operated at 250 kVp, with HVL = 1.6 mm Cu (additional filtration of 2.0 mm Al and 0.5 mm Cu).
Animal studies were performed according to the European Community Council Directive 2010/63/EU and were approved by the local Ethical Committee for Animal Experiments of the ENEA.
Cells were cultured as neurospheres in selective medium DMEM/F12 supplemented with 0.6% glucose, 25 mg/ml insulin, 60 mg/ml N-acetyl-L-cysteine, 2 mg/ml, heparin, 20 ng/ml EGF, 20 ng/ml bFGF (Peprotech, Rocky Hill, NJ), penicillin-streptomycin and B27 supplement without vitamin A. For the neurosphere-forming assay, cells were plated at clonal density (1–2 cells/mm2) into 96-well plates and cultured in selective medium as described above. Unless otherwise indicated, media and supplements for cell culture were purchased from Gibco-Invitrogen (Carlsbad, CA) and chemicals were purchased from Sigma-Aldrich (St Louis, MO).
For the morphometric analysis of neurospheres, images were captured with a Leica digital camera, and analyzed by image analysis software LASCore (Leica Microsystems, Milan, Italy).
Flow Cytometric Analysis
Briefly, two million cells were fixed with 1 ml Fixation/Permeabilization solution (BD Biosciences, San Jose, CA), vortexed and incubated at 4 °C. Cells were centrifuged, and pellets were resuspended in 1 ml of PI/RNase staining buffer (BD Biosciences). Samples were analyzed by flow cytometry using a FACS Calibur flow cytometer (BD Biosciences). For each sample, at least 1 × 105 cells were analyzed. Cell cycle distribution and hypodiploid DNA content were calculated by Cell Quest software (BD Biosciences). For endogenous visualization of γ-H2AX by FACS, we used anti-phospho γ-H2AX, (Ser139) (# 16–202, Upstate Biotechnology Inc., Lake Placid, NY).
RNA isolation and real-time qPCR
RNA isolation from cells and MBs (obtained from the ENEA archive of frozen tumors) was performed with miRNeasy Mini Kit (# 217004; QIAGEN, Milan, Italy.) After quantification, 2 μg of total RNA was reverse transcribed with High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA), and qPCR was carried out by StepOnePlus™ Real-Time PCR System (Applied Biosystems) using Power SYBR® Green PCR Master Mix (Applied Biosystems). Oligonucleotide primers used for quantitative RT-PCR are listed in Supplementary Information file (Table S2). Reactions were performed in triplicate from each biological replicate. Relative gene expression was quantified using Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as house-keeping gene. The ΔΔCt quantitative method was used to normalize expression of the reference gene and to calculate the relative expression levels of target genes.
miRNA expression was performed as described earlier23; analysis was carried out with TaqMan® miRNA Assay (ThermoFisher Scientific, Milan, Italy) for hsa-miR-125b-5p (# A25576 Assay ID: 477885_mir) and for U6 snRNA (# Assay ID: 001973).
Western blot assay
Cells were lysed with T-PER® Tissue Protein Extraction Reagent (# 78510; Pierce Biotechnology, Rockford, IL) added with protease inhibitors. Lysates were separated on pre-cast gels (Bio-Rad Laboratories; Hercules, CA) and immunoblotted using standard procedures. Anti-p21 (C19) (# sc-397; Santa Cruz Biotechnology, Santa Cruz, CA), anti-Bax (N20) (# sc493, Santa Cruz Biotechnology), anti Bcl-2 (N19) (# sc-492, Santa Cruz Biotechnology), anti-Gli1 (# NB600-600, Novus Biologicals, Littleton, CO, USA) and HRP-conjugated secondary antisera (Santa Cruz Biotechnology) were used followed by enhanced chemiluminescence (ECL Amersham, Amersham, UK). Densitometry calculations for western blot were calculated using ImageJ software, verifying for non-saturation and subtracting background. Band intensities were sampled three times and normalized against HSP90 (# 4874; Cell Signaling Technology Inc., Danvers, MA).
Silencing of Nanog in GCPs
Transfection of siRNA duplexes (40 nM) directed against the Nanog mRNA coding sequence (siGENOME Mouse Nanog (71950) siRNA SMARTpool; Dharmacon, Thermo Fisher Scientific, Waltham, MA) was carried out using the INTERFERin™ siRNA Transfection Reagent (Polyplus Transfection, New York, NY) according to the manufacturer’s instructions. Control transfections were carried out with a pool of validated siRNA controls (siGENOME Non-Targeting siRNA Pool #1, D-001206-13-20, Dharmacon). GCPs were isolated at P2 and transfected with siRNAs the same day, the following day cells were seeded and irradiated.
Viability and apoptosis
Viability and apoptosis of GCPs were performed using CellTiter-Glo® Luminescent Cell Viability Assay (# G7570; Promega Madison, WI, USA) and Caspase-Glo® 3/7 Assay (# G8091; Promega) according to the manufacturer’s instructions.
Brains (n = 6 for each genotype) were collected from unirradiated and 1 Gy- irradiated WT and Ptch1 +/− mice at different experimental time points (i.e., postnatal day (P) 5, P8 and P14), fixed in 10% buffered formalin, embedded in paraffin wax according to standard techniques, sectioned and stained with hematoxylin/eosin for histology. Morphometric analysis to measure cross sectional area was carried out using imaging software NIS-Elements BR 4.00.05 (Nikon Instruments Europe B.V., Italy).
All quantitative data are presented as mean ± SD. When both genotype and dose effects were analyzed, the level of significance was determined by two-way analysis of variance with Bonferroni post-hoc tests to compare replicate means (GraphPad Software, San Diego, CA, USA). If not otherwise stated, statistical significance (P) was calculated by two-tailed Student’s t-test.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supported in part by the 7th Framework programme of the European Commission, Dark.Risk project, Grant agreement n°: 323216 and by Grant 10357 from the Associazione Italiana, Ricerca sul Cancro (AIRC). PG is a PhD student in “Molecular, Cellular and Environmental Biology”, accounting at Department of Sciences, Roma Tre University, Rome, Italy.
Electronic supplementary material
About this article
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.